Human studyImmunity · 22 Jul 2023
LL-37 cream sped up healing of diabetic foot ulcers
A randomised, double-blind trial with the antimicrobial peptide the body makes itself.
LL-37 is a human antimicrobial peptide that also promotes blood-vessel formation and the migration and growth of skin cells. In this trial, run in Jakarta, people with diabetic foot ulcers applied LL-37 cream or placebo for 4 weeks.
Wounds were measured weekly and inflammatory markers and bacteria in the wound were analysed. The authors concluded that LL-37 cream effectively and safely accelerates healing.
In three points
- Randomised, double-blind human trial
- Faster healing in 4 weeks
- An antimicrobial peptide found in the human body
PubMed · PubMed Central
Plain-language summary by SYNTRA LABS based on the original publication and checked against its source. It is not medical advice or a recommendation for use. SYNTRA LABS compounds are for research use only and not for human consumption.